{"id":"https://openalex.org/W2331669409","doi":"https://doi.org/10.2174/157018011794578187","title":"Novel Aglycones of Steroidal Glycoalkaloids as Potent Tyrosine Kinase Inhibitors: Role in VEGF and EGF Receptors Targeted Angiogenesis","display_name":"Novel Aglycones of Steroidal Glycoalkaloids as Potent Tyrosine Kinase Inhibitors: Role in VEGF and EGF Receptors Targeted Angiogenesis","publication_year":2011,"publication_date":"2011-02-11","ids":{"openalex":"https://openalex.org/W2331669409","doi":"https://doi.org/10.2174/157018011794578187","mag":"2331669409"},"language":"en","primary_location":{"id":"doi:10.2174/157018011794578187","doi":"https://doi.org/10.2174/157018011794578187","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157018011794578187","pdf_url":null,"source":{"id":"https://openalex.org/S106940122","display_name":"Letters in Drug Design & Discovery","issn_l":"1570-1808","issn":["1570-1808","1875-628X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Letters in Drug Design &amp; Discovery","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058446048","display_name":"Salman Akhtar","orcid":"https://orcid.org/0000-0003-2921-3950","observed_orcids":["https://orcid.org/0000-0003-2921-3950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Salman Akhtar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111500705","display_name":"Othman A. Al\u2010Sagair","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Othman A. Al-Sagair","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077202623","display_name":"Jamal Mohammad Arif","orcid":"https://orcid.org/0000-0002-9491-3390","observed_orcids":["https://orcid.org/0000-0002-9491-3390"]},"institutions":[{"id":"https://openalex.org/I189949046","display_name":"Integral University","ror":"https://ror.org/039zd5s34","country_code":"IN","type":"education","lineage":["https://openalex.org/I189949046"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Jamal M. Arif","raw_affiliation_strings":["Departments of Biotechnology, Microbiology and Bioinformatics, Integral University, Lucknow, 226026, India.,India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Biotechnology, Microbiology and Bioinformatics, Integral University, Lucknow, 226026, India.,India","institution_ids":["https://openalex.org/I189949046"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5077202623"],"corresponding_institution_ids":["https://openalex.org/I189949046"],"apc_list":{"value":2300,"currency":"USD","value_usd":2300},"apc_paid":null,"fwci":0.3882,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.49180328,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"8","issue":"3","first_page":"205","last_page":"215"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5396000146865845,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.5396000146865845,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12215","display_name":"Phytochemical Studies and Bioactivities","score":0.420199990272522,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/steroidal-glycoalkaloids","display_name":"steroidal glycoalkaloids","score":0.968999981880188},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8069999814033508},{"id":"https://openalex.org/keywords/antiangiogenic-drugs","display_name":"antiangiogenic drugs","score":0.7620000243186951},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8870000243186951},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.7879999876022339},{"id":"https://openalex.org/keywords/vegfr1","display_name":"VEGFR1","score":0.9620000123977661},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tomatidine","display_name":"tomatidine","score":0.8600000143051147},{"id":"https://openalex.org/keywords/solasodine","display_name":"solasodine","score":0.8999999761581421},{"id":"https://openalex.org/keywords/solanidine","display_name":"solanidine","score":0.8849999904632568},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7149999737739563},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.6980000138282776},{"id":"https://openalex.org/keywords/in-silico-toxicity-prediction","display_name":"in silico toxicity prediction","score":0.5789999961853027},{"id":"https://openalex.org/keywords/multi-target-inhibitors","display_name":"multi-target inhibitors","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.782146692276001},{"id":"https://openalex.org/C2776539811","wikidata":"https://www.wikidata.org/wiki/Q4830631","display_name":"Axitinib","level":4,"score":0.7725105285644531},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7066916227340698},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6501080989837646},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5356009006500244},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.49598178267478943},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.45546942949295044},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.33685216307640076},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3208678364753723},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2984720468521118},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.27737167477607727},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15987727046012878},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13803315162658691},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11425575613975525},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0965387225151062}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/157018011794578187","doi":"https://doi.org/10.2174/157018011794578187","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157018011794578187","pdf_url":null,"source":{"id":"https://openalex.org/S106940122","display_name":"Letters in Drug Design & Discovery","issn_l":"1570-1808","issn":["1570-1808","1875-628X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Letters in Drug Design &amp; Discovery","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W138171996","https://openalex.org/W1495323566","https://openalex.org/W1888812015","https://openalex.org/W1970658820","https://openalex.org/W1974601949","https://openalex.org/W1975733812","https://openalex.org/W1984627743","https://openalex.org/W1991786188","https://openalex.org/W1999073714","https://openalex.org/W1999769620","https://openalex.org/W2009313526","https://openalex.org/W2010240511","https://openalex.org/W2017205210","https://openalex.org/W2025272925","https://openalex.org/W2029739021","https://openalex.org/W2030178248","https://openalex.org/W2040862407","https://openalex.org/W2046477257","https://openalex.org/W2051163038","https://openalex.org/W2056638877","https://openalex.org/W2060277643","https://openalex.org/W2084529417","https://openalex.org/W2097212878","https://openalex.org/W2104370191","https://openalex.org/W2112099875","https://openalex.org/W2120164517","https://openalex.org/W2127553917","https://openalex.org/W2128307445","https://openalex.org/W2131257519","https://openalex.org/W2135732933","https://openalex.org/W2152964937","https://openalex.org/W2158534713","https://openalex.org/W2415368345"],"related_works":["https://openalex.org/W2954555122","https://openalex.org/W2744624393","https://openalex.org/W2282049098","https://openalex.org/W2360628596","https://openalex.org/W138171996","https://openalex.org/W189716430","https://openalex.org/W1971340381","https://openalex.org/W1967606591","https://openalex.org/W2228310877","https://openalex.org/W2338585071"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
